4-HYDROXYANDROSTENEDIONE ALONE AND IN COMBINATION WITH ZOLADEX IN PREMENOPAUSAL BREAST-CANCER

被引：0
|
作者：
STEIN, RC
DOWSETT, M
HEDLEY, A
COOMBES, RC
机构：
[1] ST GEORGES HOSP,CLIN ONCOL UNIT,LONDON SW17 0RE,ENGLAND
[2] CHELSEA HOSP WOMEN,LONDON SW3 6LT,ENGLAND
来源：
BRITISH JOURNAL OF CANCER | 1989年 / 59卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：824 / 824
页数：1
相关论文
共 50 条
  • [21] INFLUENCE OF AMINOGLUTETHIMIDE ON PLASMA ESTROGEN-LEVELS IN BREAST-CANCER PATIENTS ON 4-HYDROXYANDROSTENEDIONE TREATMENT
    LONNING, PE
    DOWSETT, M
    JONES, A
    EKSE, D
    JACOBS, S
    MCNEIL, F
    JOHANNESSEN, DC
    POWLES, TJ
    BREAST CANCER RESEARCH AND TREATMENT, 1992, 23 (1-2) : 57 - 62
  • [22] A PHASE-II STUDY OF 4-HYDROXYANDROSTENEDIONE (4OHA) IN POST MENOPAUSAL BREAST-CANCER
    BOWMAN, A
    STEWART, ME
    DOWSETT, M
    GASKELL, D
    OBRIEN, ME
    ECCLES, DM
    CHETTY, U
    RODGER, A
    LEONARD, RCF
    SMYTH, JF
    BRITISH JOURNAL OF CANCER, 1990, 62 (03) : 521 - 521
  • [23] MEDICAL CASTRATION WITH ZOLADEX - A CONSERVATIVE APPROACH TO PREMENOPAUSAL BREAST-CANCER
    BRAMBILLA, C
    ESCOBEDO, A
    ARTIOLI, R
    LECHUGA, MJ
    MOTTA, M
    BONADONNA, G
    TUMORI, 1991, 77 (02) : 145 - 150
  • [24] TREATMENT OF ADVANCED POSTMENOPAUSAL BREAST-CANCER WITH AN AROMATASE INHIBITOR, 4-HYDROXYANDROSTENEDIONE - PHASE-II REPORT
    GOSS, PE
    POWLES, TJ
    DOWSETT, M
    HUTCHISON, G
    BRODIE, AMH
    GAZET, JC
    COOMBES, RC
    CANCER RESEARCH, 1986, 46 (09) : 4823 - 4826
  • [25] GOSERELIN (ZOLADEX) IN PREMENOPAUSAL ADVANCED BREAST-CANCER - DURATION OF RESPONSE AND SURVIVAL
    DIXON, AR
    ROBERTSON, JFR
    JACKSON, L
    NICHOLSON, RI
    WALKER, KJ
    BLAMEY, RW
    BRITISH JOURNAL OF CANCER, 1990, 62 (05) : 868 - 870
  • [26] PLASMA AND URINARY ESTROGENS IN BREAST-CANCER PATIENTS ON TREATMENT WITH 4-HYDROXYANDROSTENEDIONE (VOL 68, PG 393, 1993)
    JOHANNESSEN
    BRITISH JOURNAL OF CANCER, 1994, 69 (03) : 626 - 626
  • [27] LHRH AGONIST ZOLADEX AND ANTI-ESTROGEN TAMOXIFEN - A RATIONAL COMBINATION IN PREMENOPAUSAL WOMEN WITH BREAST-CANCER
    ROBERTSON, JFR
    WALKER, K
    NICHOLSON, RI
    BLAMEY, RW
    BRITISH JOURNAL OF SURGERY, 1988, 75 (12) : 1271 - 1271
  • [28] DOSE-RELATED ENDOCRINE EFFECTS AND PHARMACOKINETICS OF ORAL AND INTRAMUSCULAR 4-HYDROXYANDROSTENEDIONE IN POSTMENOPAUSAL BREAST-CANCER PATIENTS
    DOWSETT, M
    CUNNINGHAM, DC
    STEIN, RC
    EVANS, S
    DEHENNIN, L
    HEDLEY, A
    COOMBES, RC
    CANCER RESEARCH, 1989, 49 (05) : 1306 - 1312
  • [29] 4-HYDROXYANDROSTENEDIONE (4-OHA) AS 2ND LINE HORMONAL-THERAPY IN ADVANCED BREAST-CANCER
    MURRAY, PA
    PERRY, L
    GILMORE, J
    PLOWMAN, PN
    BRITISH JOURNAL OF CANCER, 1988, 58 (04) : 534 - 534
  • [30] AROMATASE INHIBITION WITH 4-HYDROXYANDROSTENEDIONE IN THE TREATMENT OF POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER - A PHASE-II STUDY
    HOFFKEN, K
    JONAT, W
    POSSINGER, K
    KOLBEL, M
    KUNZ, T
    WAGNER, H
    BECHER, R
    CALLIES, R
    FRIEDERICH, P
    WILLMANNS, W
    MAASS, H
    SCHMIDT, CG
    JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (05) : 875 - 880
12345